エピソード

  • Sub-two-hour marathon, spooky houses explained and why is UK health in decline?

    Sub-two-hour marathon, spooky houses explained and why is UK health in decline?
    2026/04/30
    Madeleine Finlay sits down with co-host and Guardian science editor Ian Sample to talk through three eye-catching stories from the week, including the news that the number of years people in the UK are spending in good health has declined compared with a decade ago. Also on the agenda is the science, tech and nutrition behind two runners at this weekend’s London marathon breaking the two-hour threshold, and an answer to why some old houses feel particularly spooky. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    20 分
  • What is a food intolerance, and how do you know if you have one?

    What is a food intolerance, and how do you know if you have one?
    2026/04/28
    Social media is awash with content about food intolerances and the symptoms to look out for. But figuring out whether you actually have one, and what’s triggering it, is surprisingly difficult. One avenue people are gravitating towards is at-home testing. Madeleine Finlay sits down with health and lifestyle journalist Rebecca Seal to unpick the science behind these tests. Rebecca explains how they purport to work, how accurate they actually are, and how we can all investigate what we might be intolerant to, without breaking the bank. Rebecca’s book Irritated: The Allergy Epidemic and What We Can Do About It, is out now.. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    18 分
  • Muons, massive waves and restored sight: the winners at the ‘Oscars of science’

    Muons, massive waves and restored sight: the winners at the ‘Oscars of science’
    2026/04/23
    Madeleine Finlay sits down with science editor Ian Sample to hear about some of the winners of the Breakthrough Prize, which held its ceremony in LA last weekend. Each prize is worth $3m and they’re awarded in physics, maths and life sciences. Madeleine and Ian hear from molecular biologist Jean Bennett, who shared a life sciences prize for her work developing the world’s first FDA-approved gene augmented therapy for sight loss. She explains how a chance encounter while dissecting a brain in medical school led her on a 25-year journey to develop the treatment.. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    16 分
  • Mythos: are fears over new AI model panic or PR?

    Mythos: are fears over new AI model panic or PR?
    2026/04/21
    Earlier this month the AI company Anthropic said it had created a model so powerful that, out of a sense of responsibility, it was not going to release it to the public. Anthropic says the model, Mythos Preview, excels at spotting and exploiting vulnerabilities in software, and could pose a severe risk to economies, public safety and national security. But is this the whole story? Some experts have expressed scepticism about the extent of the model’s capabilities. Ian Sample hears from Aisha Down, a reporter covering artificial intelligence for the Guardian, to find what the decision to limit access to Mythos reveals about Anthropic’s strategy, and whether the model might finally spur more regulation of the industry.. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    16 分
  • The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed

    The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed
    2026/04/16
    Madeleine Finlay sits down with co-host and science editor Ian Sample to discuss three eye-catching stories from the week, including a review into the effectiveness of a new class of Alzheimer’s drug that was once hailed as a game-changer in slowing the progress of the disease. Also on the agenda is the news that the world could be heading for a ‘super El Niño’ this summer and a study exploring whether conversations about dull topics really are as boring as we expect them to be. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    21 分
  • Helium: the invisible gas that powers AI, and why it’s in short supply

    Helium: the invisible gas that powers AI, and why it’s in short supply
    2026/04/14
    Alongside the oil and gas stranded in the strait of Hormuz is another commodity vital to today’s economy: helium. It is a critical element in all kinds of areas from MRI machines to the Large Hadron Collider, and even deep-sea diving. It is also integral to the AI boom. And this isn’t the first time its fragile global supply chain has been threatened. So why is helium so useful, and what will happen if the shortage continues? Ian Sample hears from co-host Madeleine Finlay, and from Sophia Hayes, professor of chemistry at Washington University in St. Louis. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    16 分
  • Everything you need to know about Artemis II so far

    Everything you need to know about Artemis II so far
    2026/04/09
    This week Artemis II’s four-astronaut crew broke Apollo 13’s distance record, becoming the humans to travel the farthest from Earth. Now on their way home, the team has experienced tech malfunctions, views like no other and moments of intense emotion, all in under 10 days. To find out about all the highs and lows of the mission, Madeleine Finlay hears from the Guardian’s science editor, Ian Sample. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    19 分
  • Can we eradicate a second human disease?

    Can we eradicate a second human disease?
    2026/04/07
    The number of human cases of guinea worm, a painful and debilitating tropical illness, fell to a record low of just 10 last year, according to the Carter Centre, the foundation set up by the late former US president Jimmy Carter. But despite years-long declines, it remains almost impossible to completely eradicate the parasite. Only one human illness has been entirely eradicated: smallpox. Why is it so difficult, and could guinea worm one day be the second? Ian Sample hears from co-host Madeleine Finlay, and David Molyneux, emeritus professor of tropical disease microbiology at the Liverpool School of Tropical Medicine. Help support our independent journalism at theguardian.com/sciencepod
    続きを読む 一部表示
    16 分